Cargando…
Phenylethanoid glycosides as a possible COVID-19 protease inhibitor: a virtual screening approach
From the beginning of pandemic, more than 240 million people have been infected with a death rate higher than 2%. Indeed, the current exit strategy involving the spreading of vaccines must be combined with progress in effective treatment development. This scenario is sadly supported by the vaccine’s...
Autores principales: | Bernardi, Mario, Ghaani, Mohammad Reza, Bayazeid, Omer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565174/ https://www.ncbi.nlm.nih.gov/pubmed/34731296 http://dx.doi.org/10.1007/s00894-021-04963-2 |
Ejemplares similares
-
Complete biosynthesis of the phenylethanoid glycoside verbascoside
por: Yang, Yihan, et al.
Publicado: (2023) -
In silico screening of phenylethanoid glycosides, a class of pharmacologically active compounds as natural inhibitors of SARS-CoV-2 proteases
por: Cheohen, Caio Felipe de Araujo Ribas, et al.
Publicado: (2023) -
Phenylethanoid Glycosides of Cistanche on menopausal syndrome model in mice
por: Tian, Shuo, et al.
Publicado: (2017) -
Highly Efficient Adsorption of Phenylethanoid Glycosides on Mesoporous Carbon
por: Xu, Helin, et al.
Publicado: (2019) -
Research Progress and Trends of Phenylethanoid Glycoside Delivery Systems
por: Huang, Jin, et al.
Publicado: (2022)